ABOS
Acumen
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ABOS Profile
Acumen Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company that developing novel targeted therapeutics for Alzheimer's disease
427 Park St., Charlottesville, VA 22902
--
Acumen Pharmaceuticals, Inc., was incorporated in Delaware in 1996. The company is a clinical-stage biopharmaceutical company that is developing a new disease-modifying approach to target what the company believes is a key root cause of Alzheimer's disease, or AD. Alzheimer's disease is a progressive neurodegenerative disease of the brain that causes loss of memory and cognitive function, and ultimately death.